HKEX: 9966 - Alphamab Oncology

Yield per half year: +39.22%
Dividend yield: 0.00%
Sector: Healthcare

Current price
3.23 HK$
Average price
3.95 HK$ +22.32%

Price based on EPS
5.32 HK$ +64.84%
Discount price Net Income
2.58 HK$ -20.2%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 5.32 HK$
Current price = 3.23 HK$ (difference = +64.84%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -5.44 HK$
Current price = 3.23 HK$ (difference = -268.43%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -2.42 HK$
Current price = 3.23 HK$ (difference = -174.87%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription